Page last updated: 2024-10-29

avapro and Vascular Malformations

avapro has been researched along with Vascular Malformations in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Vascular Malformations: A spectrum of congenital, inherited, or acquired abnormalities in BLOOD VESSELS that can adversely affect the normal blood flow in ARTERIES or VEINS. Most are congenital defects such as abnormal communications between blood vessels (fistula), shunting of arterial blood directly into veins bypassing the CAPILLARIES (arteriovenous malformations), formation of large dilated blood blood-filled vessels (cavernous angioma), and swollen capillaries (capillary telangiectases). In rare cases, vascular malformations can result from trauma or diseases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Öztürk, A1
Özcan, EE1
Özel, E1
Uyar, S1
Senaslan, Ö1

Other Studies

1 other study available for avapro and Vascular Malformations

ArticleYear
Medical treatment of an adult with uncorrected isolated interrupted aorta resulted in no complications after 4 years of follow-up.
    The American journal of case reports, 2014, Aug-04, Volume: 15

    Topics: Angiography; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Aorta, Thoracic; Biphenyl Comp

2014